MA22563A1 - Procede de preparation de derives de tetrahydrocarbazole - Google Patents

Procede de preparation de derives de tetrahydrocarbazole

Info

Publication number
MA22563A1
MA22563A1 MA22853A MA22853A MA22563A1 MA 22563 A1 MA22563 A1 MA 22563A1 MA 22853 A MA22853 A MA 22853A MA 22853 A MA22853 A MA 22853A MA 22563 A1 MA22563 A1 MA 22563A1
Authority
MA
Morocco
Prior art keywords
preparation
tetrahydrocarbazole derivatives
tetrahydrocarbazole
derivatives
Prior art date
Application number
MA22853A
Other languages
English (en)
French (fr)
Inventor
Mary Gaster Laramie
David King Francis
Young Rc
Julio Kaumann Alberto
Original Assignee
Vernalis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697363&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA22563(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vernalis Ltd filed Critical Vernalis Ltd
Publication of MA22563A1 publication Critical patent/MA22563A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA22853A 1991-06-26 1992-06-24 Procede de preparation de derives de tetrahydrocarbazole MA22563A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113802A GB9113802D0 (en) 1991-06-26 1991-06-26 Medicaments

Publications (1)

Publication Number Publication Date
MA22563A1 true MA22563A1 (fr) 1992-12-31

Family

ID=10697363

Family Applications (1)

Application Number Title Priority Date Filing Date
MA22853A MA22563A1 (fr) 1991-06-26 1992-06-24 Procede de preparation de derives de tetrahydrocarbazole

Country Status (34)

Country Link
US (2) US5464864A (enExample)
EP (1) EP0591280B1 (enExample)
JP (1) JP3261502B2 (enExample)
KR (1) KR100251571B1 (enExample)
CN (1) CN1034072C (enExample)
AP (1) AP344A (enExample)
AT (1) ATE170746T1 (enExample)
BR (2) BR9206237A (enExample)
CA (1) CA2113726C (enExample)
CZ (3) CZ282083B6 (enExample)
DE (2) DE69226953T2 (enExample)
DK (1) DK0591280T3 (enExample)
FI (1) FI103967B1 (enExample)
GB (1) GB9113802D0 (enExample)
HU (1) HU218907B (enExample)
IE (1) IE922062A1 (enExample)
IL (4) IL117105A (enExample)
LU (1) LU90939I2 (enExample)
MA (1) MA22563A1 (enExample)
MX (1) MX9203444A (enExample)
NL (1) NL300103I2 (enExample)
NO (2) NO304774B1 (enExample)
NZ (1) NZ243288A (enExample)
PL (3) PL169392B1 (enExample)
PT (1) PT100620B (enExample)
RU (1) RU2137474C1 (enExample)
SA (1) SA92130141B1 (enExample)
SG (1) SG47877A1 (enExample)
SI (1) SI9200125B (enExample)
SK (3) SK280907B6 (enExample)
TW (1) TW214544B (enExample)
UA (1) UA41254C2 (enExample)
WO (1) WO1993000086A1 (enExample)
ZA (1) ZA924658B (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9226530D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
GB9226566D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5616603A (en) * 1995-05-26 1997-04-01 Smithkline Beecham Plc Enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5618948A (en) * 1995-05-26 1997-04-08 Smithkline Beecham P.L.C. Process for preparing an enantiomer of a carbazole derivative
EP0749962B1 (en) * 1995-06-23 2000-11-02 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles
US5917054A (en) * 1995-07-18 1999-06-29 Smithkline Beecham P.L.C. Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9723061D0 (en) * 1997-10-31 1998-01-07 Vanguard Medica Ltd Medicaments
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
GB9808069D0 (en) * 1998-04-16 1998-06-17 Vanguard Medica Ltd Novel processes
GB9817911D0 (en) * 1998-08-17 1998-10-14 Vanguard Medica Ltd New use
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
KR100752549B1 (ko) * 2001-09-28 2007-08-30 에프. 호프만-라 로슈 아게 카르베딜올의 유사다형태
RU2340619C2 (ru) 2002-06-21 2008-12-10 Сувен Лайф Сайенсиз Лимитед Новые тетрациклические арилсульфонилиндолы с аффинностью к серотониновым рецепторам, пригодные в качестве лекарственных средств, способ их получения и содержащие их фармацевтические композиции
EP1537113B9 (en) 2002-06-21 2010-05-26 Suven Life Sciences Limited Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
ES2425143T3 (es) 2002-11-28 2013-10-11 Suven Life Sciences Limited N-Arilsulfonil-3-aminoalcoxiindoles
US7875605B2 (en) 2002-11-28 2011-01-25 Suven Life Sciences Limited N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
KR100739987B1 (ko) 2002-12-18 2007-07-16 수벤 라이프 사이언시스 리미티드 세로토닌 수용체 친화력을 가지는 테트라사이클릭 3-치환인돌
RU2430088C2 (ru) * 2004-07-14 2011-09-27 Центарис Гмбх Производные тетрагидрокарбазола и фармацевтическая композиция на их основе
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
CN101500996B (zh) * 2006-08-07 2012-07-04 埃科特莱茵药品有限公司 (3-胺基-1,2,3,4-四氢-9h-咔唑-9-基)-乙酸衍生物
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios
US20090069399A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched frovatriptan
EP2240022B1 (en) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
WO2010073253A1 (en) * 2008-12-22 2010-07-01 Natco Pharma Limited Method for preparing an optically active frovatriptan
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
US9204906B2 (en) 2009-10-22 2015-12-08 Nuvasive, Inc. Posterior cervical fusion system and techniques
US10098674B2 (en) 2009-10-22 2018-10-16 Nuvasive, Inc. System and method for posterior cervical fusion
WO2013016223A2 (en) 2011-07-22 2013-01-31 The University Of Chicago Treatments for migraine and related disorders
US9394314B2 (en) 2012-12-21 2016-07-19 Map Pharmaceuticals, Inc. 8′-hydroxy-dihydroergotamine compounds and compositions
EP2816030A1 (en) 2013-06-20 2014-12-24 Duke Chem, S. A. Process for the preparation of frovatriptan and its enantiomer
GB201312768D0 (en) * 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan
WO2025038666A2 (en) * 2023-08-13 2025-02-20 GATC Health Corp Compounds and methods for treating addiction
CN119499195A (zh) * 2024-11-26 2025-02-25 青岛国信制药有限公司 一种快速吸收琥珀酸呋罗曲坦片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642816A (en) * 1967-08-10 1972-02-15 Sterling Drug Inc 3-acetamido-1 2 3 4-tetrahydrocarbazole
US4062864A (en) * 1968-01-24 1977-12-13 Sterling Drug Inc. 3-Hydroxy carbazole derivatives
US3959309A (en) * 1968-01-24 1976-05-25 Sterling Drug Inc. 3-Amido-1,2,3,4-tetrahydrocarbazoles
US3592824A (en) * 1970-03-12 1971-07-13 Miles Lab 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
US4172834A (en) * 1971-08-16 1979-10-30 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles
EP0115607A1 (de) * 1983-01-04 1984-08-15 MERCK PATENT GmbH Tetrahydrocarbazolderivate

Also Published As

Publication number Publication date
CZ282327B6 (cs) 1997-06-11
CA2113726A1 (en) 1993-01-07
NO934800L (no) 1993-12-23
DK0591280T3 (da) 1999-02-15
ZA924658B (en) 1993-12-24
NO2005011I2 (no) 2008-02-11
HUT68961A (en) 1995-08-28
FI935842A0 (fi) 1993-12-23
AU1977592A (en) 1993-01-25
PL169410B1 (pl) 1996-07-31
JPH06508827A (ja) 1994-10-06
IL102322A0 (en) 1993-01-14
FI935842A7 (fi) 1993-12-23
DE69226953D1 (de) 1998-10-15
PT100620B (pt) 1999-01-29
BR9206237A (pt) 1995-04-11
KR100251571B1 (ko) 2000-07-01
DE10299042I1 (de) 2003-02-20
NL300103I1 (nl) 2002-12-02
AU652842B2 (en) 1994-09-08
SI9200125B (en) 2001-12-31
LU90939I2 (fr) 2002-09-24
PT100620A (pt) 1993-09-30
SK280906B6 (sk) 2000-09-12
IL117104A (en) 1997-09-30
DE10299042I2 (de) 2005-02-03
FI103967B (fi) 1999-10-29
CA2113726C (en) 2008-02-19
IL117105A (en) 1998-01-04
IL117104A0 (en) 1996-06-18
MX9203444A (es) 1993-12-01
UA41254C2 (uk) 2001-09-17
DE69226953T2 (de) 1999-05-12
NO934800D0 (no) 1993-12-23
FI103967B1 (fi) 1999-10-29
CZ150696A3 (en) 1997-06-11
NL300103I2 (nl) 2003-02-03
BR1100460A (pt) 2000-07-18
RU2137474C1 (ru) 1999-09-20
HK1014669A1 (en) 1999-09-30
CZ286193A3 (en) 1994-07-13
HU218907B (hu) 2000-12-28
CN1034072C (zh) 1997-02-19
AP344A (en) 1994-07-05
US5464864A (en) 1995-11-07
JP3261502B2 (ja) 2002-03-04
SA92130141B1 (ar) 2005-12-18
IE922062A1 (en) 1992-12-30
CZ282061B6 (cs) 1997-05-14
WO1993000086A1 (en) 1993-01-07
PL169392B1 (pl) 1996-07-31
EP0591280A1 (en) 1994-04-13
CZ150596A3 (en) 1997-05-14
AP9200403A0 (en) 1992-07-31
NO304774B1 (no) 1999-02-15
CN1069726A (zh) 1993-03-10
IL102322A (en) 1997-09-30
ATE170746T1 (de) 1998-09-15
NO2005011I1 (no) 2005-05-18
PL171034B1 (en) 1997-02-28
SK131993A3 (en) 1994-06-08
SK280905B6 (sk) 2000-09-12
NZ243288A (en) 1994-09-27
EP0591280B1 (en) 1998-09-09
SK280907B6 (sk) 2000-09-12
SG47877A1 (en) 1998-04-17
US5637611A (en) 1997-06-10
TW214544B (enExample) 1993-10-11
IL117105A0 (en) 1996-06-18
SI9200125A (en) 1992-12-31
GB9113802D0 (en) 1991-08-14
CZ282083B6 (cs) 1997-05-14

Similar Documents

Publication Publication Date Title
MA22563A1 (fr) Procede de preparation de derives de tetrahydrocarbazole
MA22539A1 (fr) Procede de preparation de derives de quinuclidine
MA21983A1 (fr) Procede pour la preparation de derives de quinolone .
FR2636330B1 (fr) Procede de preparation de derives de morphinane
FI915231A7 (fi) Mikrobiologinen menetelmä hydroksyloitujen pyratsiinijohdannaisten valmistamiseksi
FR2741346B1 (fr) Nouveau procede de preparation de derives phenylimidazolidine
FR2680506B1 (fr) Procede de preparation de derives de la beta-phenylisoserine et leur utilisation.
FR2627493B1 (fr) Procede de preparation de derives d'isoquinoleine
MA21984A1 (fr) Procede pour la preparation de derives de quilinone .
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
FI933755A7 (fi) Menetelmä trans-piperidiini-2,5-dikarboksylaattien valmistamiseksi
MA23081A1 (fr) Procede de preparation de derives d'indolone
DK56694A (da) Fremgangsmåde til fremstilling af cephemderivater
MA21499A1 (fr) Procede de preparation de nouveaux derives de la i-arylsylfonyl 2-pyrrolidinone.
FR2601019B1 (fr) Procede de preparation de derives de la moranoline
NO925007D0 (no) Fremgangsmaate for fremstilling av benzofuranylimidazolderivater
FR2688505B1 (fr) Nouveau procede de preparation de 4-pyrimidinones.
FI913656A7 (fi) Menetelmä alkyyli-6-pyridatsiinijohdannaisten valmistamiseksi
FR2681068B1 (fr) Procede de preparation de l'isomere dextrogyre d'un derive de l'isoindolinone.
FR2661911B1 (fr) Procede de preparation de derives de la thieno-triazolo-diazepine.
FR2647107B1 (fr) Procede de preparation de derives aromatiques fluores
MA20108A1 (fr) Procede de preparation de derives de cepheme
MA22589A1 (fr) Procede de preparation de l'isomere dextrogyre d'un derive de l'isoindolinone
FR2663320B1 (fr) Procede de preparation de dialcoxybutenes.
FR2616431B1 (fr) Procede de preparation de derives de la (trans)-4-phenyl-l-proline